HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 1 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
A bill to be entitled 1
An act relating to pharmaceutical products containing 2
cannabis; amending s. 893.03, F.S.; excluding cannabis 3
from Schedule I listing if it is contained within a 4
pharmaceutical product approved by the United States 5
Food and Drug Administration; providing construction; 6
providing an effective date. 7
8
Be It Enacted by the Legislature of the State of Florida: 9
10
Section 1. Paragraph (c) of subsection (1) of sectio n 11
893.03, Florida Statutes, is amended to read: 12
893.03 Standards and schedules. —The substances enumerated 13
in this section are controlled by this chapter. The controlled 14
substances listed or to be listed in Schedules I, II, III, IV, 15
and V are included by whatever official, common, usual, 16
chemical, trade name, or class designated. The provisions of 17
this section shall not be construed to include within any of the 18
schedules contained in this section any excluded drugs listed 19
within the purview of 21 C.F.R. s. 1308.22, styled "Excluded 20
Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical 21
Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted 22
Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt 23
Anabolic Steroid Products." 24
(1) SCHEDULE I.—A substance in Schedule I has a high 25
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 2 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
potential for abuse and has no currently accepted medical use in 26
treatment in the United States and in its use under medical 27
supervision does not meet accepted safety standards. The 28
following substances are controlled in Sche dule I: 29
(c) Unless specifically excepted or unless listed in 30
another schedule, any material, compound, mixture, or 31
preparation that contains any quantity of the following 32
hallucinogenic substances or that contains any of their salts, 33
isomers, including o ptical, positional, or geometric isomers, 34
homologues, nitrogen -heterocyclic analogs, esters, ethers, and 35
salts of isomers, homologues, nitrogen -heterocyclic analogs, 36
esters, or ethers, if the existence of such salts, isomers, and 37
salts of isomers is possib le within the specific chemical 38
designation or class description: 39
1. Alpha-Ethyltryptamine. 40
2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-41
oxazoline). 42
3. Aminorex (2-Amino-5-phenyl-2-oxazoline). 43
4. DOB (4-Bromo-2,5-dimethoxyamphetamine). 44
5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 45
6. Bufotenine. 46
7. Cannabis, except if it is contained within a 47
pharmaceutical product approved by the United States Food and 48
Drug Administration. 49
8. Cathinone. 50
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 3 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
9. DET (Diethyltryptamine). 51
10. 2,5-Dimethoxyamphetamine. 52
11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine). 53
12. DMT (Dimethyltryptamine). 54
13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine 55
analog of phencyclidine). 56
14. JB-318 (N-Ethyl-3-piperidyl benzilate). 57
15. N-Ethylamphetamine. 58
16. Fenethylline. 59
17. 3,4-Methylenedioxy-N-hydroxyamphetamine. 60
18. Ibogaine. 61
19. LSD (Lysergic acid diethylamide). 62
20. Mescaline. 63
21. Methcathinone. 64
22. 5-Methoxy-3,4-methylenedioxyamphetamine. 65
23. PMA (4-Methoxyamphetamine). 66
24. PMMA (4-Methoxymethamphetamine). 67
25. DOM (4-Methyl-2,5-dimethoxyamphetamine). 68
26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 69
27. MDA (3,4-Methylenedioxyamphetamine). 70
28. JB-336 (N-Methyl-3-piperidyl benzilate). 71
29. N,N-Dimethylamphetamine. 72
30. Parahexyl. 73
31. Peyote. 74
32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine 75
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 4 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
analog of phencyclidine). 76
33. Psilocybin. 77
34. Psilocyn. 78
35. Salvia divinorum, except for any drug product approved 79
by the United States Food and Drug Administration which contains 80
Salvia divinorum or its isomers, esters, ethers, salts, and 81
salts of isomers, esters, and ethers, if the existence of such 82
isomers, esters, ethers, and salts is possible within the 83
specific chemical designation. 84
36. Salvinorin A, except for any drug product approved by 85
the United States Food and Drug Administration which contains 86
Salvinorin A or its isomers, esters, ethers, salts, and salts of 87
isomers, esters, and ethers, if the existence of such isomers, 88
esters, ethers, and salts is possible within the specific 89
chemical designation. 90
37. Xylazine. 91
38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine) 92
(Thiophene analog of phencyclidine). 93
39. 3,4,5-Trimethoxyamphetamine. 94
40. Methylone (3,4-Methylenedioxymethcathinone). 95
41. MDPV (3,4-Methylenedioxypyrovalerone). 96
42. Methylmethcathinone. 97
43. Methoxymethcathinone. 98
44. Fluoromethcathinone. 99
45. Methylethcathinone. 100
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 5 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-101
yl)phenol) and its dimethyloctyl (C8) homologue. 102
47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-103
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-104
ol]. 105
48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 106
49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 107
50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-108
naphthoyl)indole). 109
51. BZP (Benzylpiperazine). 110
52. Fluorophenylpiperazine. 111
53. Methylphenylpiperazine. 112
54. Chlorophenylpiperazine. 113
55. Methoxyphenylpiperazine. 114
56. DBZP (1,4-Dibenzylpiperazine). 115
57. TFMPP (Trifluoromethylphenylpiperazine). 116
58. MBDB (Methylbenzodioxolylbutanamine) or (3,4 -117
Methylenedioxy-N-methylbutanamine). 118
59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 119
60. 5-Hydroxy-N-methyltryptamine. 120
61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 121
62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 122
63. Methyltryptamine. 123
64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 124
65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 125
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 6 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
66. Tyramine (4-Hydroxyphenethylamine). 126
67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 127
68. DiPT (N,N-Diisopropyltryptamine). 128
69. DPT (N,N-Dipropyltryptamine). 129
70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 130
71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 131
72. DOI (4-Iodo-2,5-dimethoxyamphetamine). 132
73. DOC (4-Chloro-2,5-dimethoxyamphetamine). 133
74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 134
75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 135
76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 136
77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 137
78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 138
79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 139
80. 2C-I (4-Iodo-2,5-dimethoxyphenethylami ne). 140
81. Butylone (3,4-Methylenedioxy-alpha-141
methylaminobutyrophenone). 142
82. Ethcathinone. 143
83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 144
84. Naphyrone (Naphthylpyrovalerone). 145
85. Dimethylone (3,4 -Methylenedioxy-N,N-146
dimethylcathinone). 147
86. 3,4-Methylenedioxy-N,N-diethylcathinone. 148
87. 3,4-Methylenedioxy-propiophenone. 149
88. 3,4-Methylenedioxy-alpha-bromopropiophenone. 150
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 7 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
89. 3,4-Methylenedioxy-propiophenone-2-oxime. 151
90. 3,4-Methylenedioxy-N-acetylcathinone. 152
91. 3,4-Methylenedioxy-N-acetylmethcathinone. 153
92. 3,4-Methylenedioxy-N-acetylethcathinone. 154
93. Bromomethcathinone. 155
94. Buphedrone (alpha -Methylamino-butyrophenone). 156
95. Eutylone (3,4-Methylenedioxy-alpha-157
ethylaminobutyrophenone). 158
96. Dimethylcathinone. 159
97. Dimethylmethcathinone. 160
98. Pentylone (3,4-Methylenedioxy-alpha-161
methylaminovalerophenone). 162
99. MDPPP (3,4-Methylenedioxy-alpha-163
pyrrolidinopropiophenone). 164
100. MDPBP (3,4-Methylenedioxy-alpha-165
pyrrolidinobutyrophenone). 166
101. MOPPP (Methoxy -alpha-pyrrolidinopropiophenone). 167
102. MPHP (Methyl-alpha-pyrrolidinohexanophenone). 168
103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 169
(Benocyclidine). 170
104. F-MABP (Fluoromethylaminobutyrophenone). 171
105. MeO-PBP (Methoxypyrrolidinobutyrophenone). 172
106. Et-PBP (Ethylpyrrolidinobutyrophenone). 173
107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 174
108. Me-EABP (Methylethylaminobutyrophenone). 175
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 8 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
109. Etizolam. 176
110. PPP (Pyrrolidinopropiophenone). 177
111. PBP (Pyrrolidinobutyrophenone). 178
112. PVP (Pyrrolidinovalerophenone) or 179
(Pyrrolidinopentiophenone). 180
113. MPPP (Methyl-alpha-pyrrolidinopropiophenone). 181
114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 182
115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 183
116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 184
117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 185
118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 186
119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 187
120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 188
121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-189
methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 190
122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 191
123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 192
124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 193
125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 194
126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 195
127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 196
128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 197
129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole). 198
130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-199
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-200
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 9 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
ol). 201
131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-202
methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-203
enyl] methanol). 204
132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-205
methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-206
1,4-dione). 207
133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene). 208
134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-209
undecanamide). 210
135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-211
undecanamide). 212
136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-213
methyloctan-2-yl)phenol). 214
137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 215
138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole). 216
139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 217
140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2-218
methoxyphenylacetyl)indole). 219
141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-220
morpholinylmethyl)pyrrolo[1,2,3 -de]-1,4-benzoxazin-6-yl]-1-221
naphthalenylmethanone). 222
142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4-223
morpholinylmethyl)pyrrolo[1,2,3 -de]-1,4-benzoxazin-6-yl]-1-224
naphthalenylmethanone). 225
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 10 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
143. Pentedrone (alpha -Methylaminovalerophenone). 226
144. Fluoroamphetamine. 227
145. Fluoromethamphetamine. 228
146. Methoxetamine. 229
147. Methiopropamine. 230
148. Methylbuphedrone (Methyl -alpha-231
methylaminobutyrophenone). 232
149. APB ((2-Aminopropyl)benzofuran). 233
150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran). 234
151. UR-144 (1-Pentyl-3-(2,2,3,3-235
tetramethylcyclopropanoyl)indole). 236
152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-237
tetramethylcyclopropanoyl)indole). 238
153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-239
tetramethylcyclopropanoyl)indole). 240
154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-241
carboxamide). 242
155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-243
iodobenzoyl)indole). 244
156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-245
carboxamide). 246
157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)-247
cyclohexylcarbamate). 248
158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid, 249
cyclohexyl ester). 250
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 11 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1-251
benzoxazin-4-one). 252
160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 253
161. 2C-H (2,5-Dimethoxyphenethylamine). 254
162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 255
163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine). 256
164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-257
methoxybenzyl)]phenethylamine). 258
165. MDMA (3,4-Methylenedioxymethamp hetamine). 259
166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 260
167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole -3-261
carboxylate). 262
168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole -3-263
carboxylate). 264
169. Fluoro AKB48 (N -Adamant-1-yl 1-265
(fluoropentyl)indazole-3-carboxamide). 266
170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-267
pentylindazole-3-carboxamide). 268
171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-269
(4-fluorobenzyl)indazole -3-carboxamide). 270
172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-271
1-pentylindazole-3-carboxamide). 272
173. Fluoro ADBICA (N -(1-Amino-3,3-dimethyl-1-oxobutan-2-273
yl)-1-(fluoropentyl)indole -3-carboxamide). 274
174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-275
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 12 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
methoxybenzyl)]phenethylamine). 276
175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-277
methoxybenzyl)]phenethylamine). 278
176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-279
(cyclohexylmethyl)indazole -3-carboxamide). 280
177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-281
carboxylate). 282
178. Fluoro-NNEI (N-Naphthalen-1-yl 1-283
(fluoropentyl)indole -3-carboxamide). 284
179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-285
(fluoropentyl)indazole -3-carboxamide). 286
180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-287
naphthoyl)indazole). 288
181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-289
1,4,4a,8,9,10,11,12b -octahydronaphtho[3,2 -c]isochromen-12-ol). 290
182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-291
(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-292
hexahydrobenzo[c]chromen -1-ol). 293
183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-294
(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-295
hexahydrobenzo[c]chromen -1-ol). 296
184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-297
6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 298
diol). 299
185. HU-243 ((6aR,8S,9S,10aR) -9-(Hydroxymethyl)-6,6-300
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 13 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-301
tetrahydro-6aH-benzo[c]chromen-1-ol). 302
186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-303
6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione). 304
187. MAPB ((2-Methylaminopropyl)benzofuran). 305
188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine). 306
189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine). 307
190. Synthetic Cannabinoids. —Unless specifically excepted 308
or unless listed in another schedule or contained within a 309
pharmaceutical product approved by the United States Food and 310
Drug Administration, any material, compound, mixture, or 311
preparation that contains any quantity of a synthetic 312
cannabinoid found to be in any of the following chemical class 313
descriptions, or homologues, nitrogen -heterocyclic analogs, 314
isomers (including optical, positional, or geometric), esters, 315
ethers, salts, and salts of homologues, nitrogen -heterocyclic 316
analogs, isomers, esters, or ethers, whenever the existence of 317
such homologues, nitrogen -heterocyclic analogs, isomers, esters, 318
ethers, salts, and salts of isomers, esters, or ethers is 319
possible within the specific chemical class or designation. 320
Since nomenclature of these synthetically produced cannabinoids 321
is not internationally standardized and may continuall y evolve, 322
these structures or the compounds of these structures shall be 323
included under this subparagraph, regardless of their specific 324
numerical designation of atomic positions covered, if it can be 325
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 14 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
determined through a recognized method of scientific tes ting or 326
analysis that the substance contains properties that fit within 327
one or more of the following categories: 328
a. Tetrahydrocannabinols. —Any tetrahydrocannabinols 329
naturally contained in a plant of the genus Cannabis, the 330
synthetic equivalents of the su bstances contained in the plant 331
or in the resinous extracts of the genus Cannabis, or synthetic 332
substances, derivatives, and their isomers with similar chemical 333
structure and pharmacological activity, including, but not 334
limited to, Delta 9 tetrahydrocannab inols and their optical 335
isomers, Delta 8 tetrahydrocannabinols and their optical 336
isomers, Delta 6a,10a tetrahydrocannabinols and their optical 337
isomers, or any compound containing a tetrahydrobenzo[c]chromene 338
structure with substitution at either or both th e 3-position or 339
9-position, with or without substitution at the 1 -position with 340
hydroxyl or alkoxy groups, including, but not limited to: 341
(I) Tetrahydrocannabinol. 342
(II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-343
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-344
ol). 345
(III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-346
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-347
ol). 348
(IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-349
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 350
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 15 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-351
2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 352
(VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-353
2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 354
(VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-355
(2,3-dimethylpentan-2-yl)-6a,7,10,10a-356
tetrahydrobenzo[c]chromene). 357
(VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-358
6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-ol). 359
(IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-360
6a,7,10,10a-tetrahydrobenzo[c]chromen -1-ol). 361
(X) Parahexyl. 362
b. Naphthoylindoles, Naphthoylindazoles, 363
Naphthoylcarbazoles, Naphthylmethylindoles, 364
Naphthylmethylindazoles, and Naphthylmethylcarbazoles. —Any 365
compound containing a naphthoylindole, naphthoylindazole, 366
naphthoylcarbazole, naphthylmethylindole, 367
naphthylmethylindazole, or naphthylmethylcarbazole structure, 368
with or without substitution on the indole, indazole, or 369
carbazole ring to any extent, whether or not substituted on the 370
naphthyl ring to any extent, including, but not limited to: 371
(I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 372
(II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1-373
naphthoyl)indole). 374
(III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 375
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 16 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole). 376
(V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 377
(VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 378
(VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 379
(VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole). 380
(IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole). 381
(X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 382
(XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 383
(XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole). 384
(XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 385
(XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1-386
naphthoyl)indole). 387
(XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole). 388
(XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 389
(XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1-390
naphthoyl)indole). 391
(XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-392
naphthoyl)indole). 393
(XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 394
(XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole). 395
(XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole). 396
(XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1-397
naphthylmethyl]indole). 398
(XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-399
naphthoyl)indole). 400
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 17 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-401
naphthoyl)indole). 402
(XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-403
naphthoyl)indole). 404
(XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 405
(XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole). 406
(XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-407
naphthoyl)indole). 408
(XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole). 409
(XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole). 410
(XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-411
naphthoyl)indole). 412
(XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1-413
naphthoyl)indole). 414
(XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1-415
naphthoyl)indole). 416
(XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1-417
naphthoyl)indole). 418
(XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1-419
naphthoyl)indole). 420
(XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole). 421
(XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1-422
naphthoyl)indazole). 423
(XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1-424
naphthoyl)indole). 425
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 18 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1-426
naphthoyl)indole). 427
(XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole). 428
(XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1-429
naphthoyl)carbazole). 430
c. Naphthoylpyrroles. —Any compound containing a 431
naphthoylpyrrole structure, with or without substitution on the 432
pyrrole ring to any extent, whether or not substituted on the 433
naphthyl ring to any e xtent, including, but not limited to: 434
(I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole). 435
(II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole). 436
(III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole). 437
(IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole). 438
(V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole). 439
(VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1-440
naphthoyl)pyrrole). 441
(VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1-442
naphthoyl)pyrrole). 443
(VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1-444
naphthoyl)pyrrole). 445
(IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1-446
naphthoyl)pyrrole). 447
(X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1-448
naphthoyl)pyrrole). 449
d. Naphthylmethylenindenes. —Any compound containing a 450
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 19 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
naphthylmethylenindene structure, with or without sub stitution 451
at the 3-position of the indene ring to any extent, whether or 452
not substituted on the naphthyl ring to any extent, including, 453
but not limited to, JWH -176 (3-Pentyl-1-454
(naphthylmethylene)indene). 455
e. Phenylacetylindoles and Phenylacetylindazoles. —Any 456
compound containing a phenylacetylindole or phenylacetylindazole 457
structure, with or without substitution on the indole or 458
indazole ring to any extent, whether or not substituted on the 459
phenyl ring to any extent, including, but not limited to: 460
(I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole). 461
(II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 462
(III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 463
(IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 464
(V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 465
(VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 466
(VII) Cannabipiperidiethanone. 467
(VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2-468
methoxyphenylacetyl)indole). 469
f. Cyclohexylphenols. —Any compound containing a 470
cyclohexylphenol structure, with or without substitution at the 471
5-position of the phenolic ring to any extent, whether or not 472
substituted on the cyclohexyl ring to any extent, including, but 473
not limited to: 474
(I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-475
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 20 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
yl)phenol). 476
(II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8) 477
homologue). 478
(III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-479
methyloctan-2-yl)phenol). 480
g. Benzoylindoles and Benzoylindazoles. —Any compound 481
containing a benzoylin dole or benzoylindazole structure, with or 482
without substitution on the indole or indazole ring to any 483
extent, whether or not substituted on the phenyl ring to any 484
extent, including, but not limited to: 485
(I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole). 486
(II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 487
(III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-488
iodo-5-nitrobenzoyl)indole). 489
(IV) Pravadoline (1 -[2-(4-Morpholinyl)ethyl]-2-methyl-3-490
(4-methoxybenzoyl)indole). 491
(V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-492
iodobenzoyl)indole). 493
(VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 494
(VII) RCS-4 C4 homologue (1-Butyl-3-(4-495
methoxybenzoyl)indole). 496
(VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-497
3-(4-methoxybenzoyl)indole). 498
h. Tetramethylcyclopropanoylindoles and 499
Tetramethylcyclopropanoylindazoles. —Any compound containing a 500
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 21 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
tetramethylcyclopropanoylindole or 501
tetramethylcyclopropanoylindazole structure, with or without 502
substitution on the indole or indazole ring to any extent, 503
whether or not substituted on the tetramethylcyclopropyl group 504
to any extent, including, but not limited to: 505
(I) UR-144 (1-Pentyl-3-(2,2,3,3-506
tetramethylcyclopropanoyl)indole). 507
(II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-508
tetramethylcyclopropanoyl)indole). 509
(III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-510
tetramethylcyclopropanoyl)indole). 511
(IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-512
tetramethylcyclopropanoyl)indole). 513
(V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl] -3-(2,2,3,3-514
tetramethylcyclopropanoyl)indole). 515
(VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-516
tetramethylcyclopropanoyl)indole). 517
(VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3-518
tetramethylcyclopropanoyl)indole). 519
(VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3-520
tetramethylcyclopropan oyl)indazole). 521
(IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-522
tetramethylcyclopropanoyl)indole). 523
(X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-524
tetramethylcyclopropanoyl)indole). 525
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 22 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole 526
carboxamides, and Adamantylindazole carboxamides. —Any compound 527
containing an adamantoyl indole, adamantoyl indazole, adamantyl 528
indole carboxamide, or adamantyl indazole carboxamide structure, 529
with or without substitution on the indole or indazole ring to 530
any extent, whether or not substituted on the adamantyl ring to 531
any extent, including, but not limited to: 532
(I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide). 533
(II) Fluoro AKB48 (N -Adamant-1-yl 1-534
(fluoropentyl)indazole -3-carboxamide). 535
(III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-536
carboxamide). 537
(IV) AM-1248 (1-(1-Methylpiperidine)methyl -3-(1-538
adamantoyl)indole). 539
(V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole). 540
(VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide). 541
(VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1-542
adamantoyl)indole). 543
j. Quinolinylindolecarboxylates, 544
Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides, 545
and Quinolinylindazolecarboxamides. —Any compound containing a 546
quinolinylindole carboxylate, quinolinylindazole carboxylate, 547
isoquinolinylindole carboxylate, isoquinolinylindazole 548
carboxylate, quinolinylindole carboxamide, quinolinylindazole 549
carboxamide, isoquinolinylindole carboxamide, or 550
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 23 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
isoquinolinylindazole carboxamide structure, with or without 551
substitution on the indole or indazole ring to any extent, 552
whether or not substituted on the quinoline or isoquinoline ring 553
to any extent, including, but not limited to: 554
(I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 555
(II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-556
carboxylate). 557
(III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole -3-558
carboxylate). 559
(IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-560
carboxylate). 561
(V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate). 562
(VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole -563
3-carboxylate). 564
(VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole -565
3-carboxylate). 566
(VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide). 567
(IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole -3-568
carboxamide). 569
k. Naphthylindolecarboxylates and 570
Naphthylindazolecarboxylates. —Any compound containing a 571
naphthylindole carboxylate or naphthylindazole carboxylate 572
structure, with or without substitution on the indole or 573
indazole ring to any extent, whether or not substituted on the 574
naphthyl ring to any extent, including, but not limited to: 575
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 24 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3-576
carboxylate). 577
(II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3-578
carboxylate). 579
(III) Fluoro SDB-005 (1-Naphthalenyl 1-580
(fluoropentyl)indazole -3-carboxylate). 581
(IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3-582
carboxylate). 583
(V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole -3-584
carboxylate). 585
l. Naphthylindole carboxamides and Naphthylindazole 586
carboxamides.—Any compound containing a naphthylindole 587
carboxamide or naphthylindazole carboxamide structure, with or 588
without substitution on the indole or indazole ring to any 589
extent, whether or not substituted on the naphthyl ring to any 590
extent, including, but not limit ed to: 591
(I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide). 592
(II) Fluoro-NNEI (N-Naphthalen-1-yl 1-593
(fluoropentyl)indole -3-carboxamide). 594
(III) Chloro-NNEI (N-Naphthalen-1-yl 1-595
(chloropentyl)indole -3-carboxamide). 596
(IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3-597
carboxamide). 598
(V) Fluoro MN-18 (N-Naphthalen-1-yl 1-599
(fluoropentyl)indazole -3-carboxamide). 600
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 25 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl 601
indazole carboxamides, Alkylcarbonyl indole carboxylates, and 602
Alkylcarbonyl indazole carbo xylates.—Any compound containing an 603
alkylcarbonyl group, including 1 -amino-3-methyl-1-oxobutan-2-yl, 604
1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3-605
phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an 606
indole carboxamide, indazole carboxamid e, indole carboxylate, or 607
indazole carboxylate, with or without substitution on the indole 608
or indazole ring to any extent, whether or not substituted on 609
the alkylcarbonyl group to any extent, including, but not 610
limited to: 611
(I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-612
pentylindole-3-carboxamide). 613
(II) Fluoro ADBICA (N -(1-Amino-3,3-dimethyl-1-oxobutan-2-614
yl)-1-(fluoropentyl)indole -3-carboxamide). 615
(III) Fluoro ABICA (N -(1-Amino-3-methyl-1-oxobutan-2-yl)-616
1-(fluoropentyl)indole -3-carboxamide). 617
(IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-618
pentylindazole-3-carboxamide). 619
(V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-620
yl)-1-(fluoropentyl)indazole -3-carboxamide). 621
(VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-622
1-pentylindazole-3-carboxamide). 623
(VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-624
oxobutan-2-yl)-1-(fluoropentyl)indazole -3-carboxamide). 625
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 26 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-626
1-(4-fluorobenzyl)indazole -3-carboxamide). 627
(IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-628
yl)-1-(4-fluorobenzyl)indazole -3-carboxamide). 629
(X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-630
(cyclohexylmethyl)indazole -3-carboxamide). 631
(XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-632
1-(cyclohexylmethyl)indazole-3-carboxamide). 633
(XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-634
yl)-1-(cyclohexylmethyl)indazole -3-carboxamide). 635
(XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-636
pentylindazole-3-carboxamide). 637
(XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-638
1-(fluoropentyl)indazole -3-carboxamide). 639
(XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-640
fluorobenzyl)indazole -3-carboxamide). 641
(XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-642
2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide). 643
(XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-644
oxobutan-2-yl)-1-(4-fluorobenzyl)indazole -3-carboxamide). 645
(XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-646
2-yl)-1-(cyclohexylmethyl)indole -3-carboxamide). 647
(XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-648
fluoropentyl)indole-3-carboxamide). 649
(XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-650
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 27 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
fluoropentyl)indazole -3-carboxamide). 651
(XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-652
(cyclohexylmethyl)indazole -3-carboxamide). 653
(XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-654
fluorobenzyl)indazole -3-carboxamide). 655
(XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-656
2-yl)-1-(cyclohexylmethyl)indazole -3-carboxylate). 657
n. Cumylindolecarboxamides and Cumylindazolecarboxamides. —658
Any compound containing a N -(2-phenylpropan-2-yl) indole 659
carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide 660
structure, with or without substitution on the indole or 661
indazole ring to any extent, whether or not substituted on the 662
phenyl ring of the cumyl group to any extent, including, but not 663
limited to: 664
(I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3-665
carboxamide). 666
(II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-667
(fluoropentyl)indole -3-carboxamide). 668
o. Other Synthetic Cannabinoids. —Any material, compound, 669
mixture, or preparation that contains any quantity of a 670
Synthetic Cannabinoid, as described in sub -subparagraphs a.-n.: 671
(I) With or without modification or replacement of a 672
carbonyl, carboxamide, alky lene, alkyl, or carboxylate linkage 673
between either two core rings, or linkage between a core ring 674
and group structure, with or without the addition of a carbon or 675
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 28 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
replacement of a carbon; 676
(II) With or without replacement of a core ring or group 677
structure, whether or not substituted on the ring or group 678
structures to any extent; and 679
(III) Is a cannabinoid receptor agonist, unless 680
specifically excepted or unless listed in another schedule or 681
contained within a pharmaceutical product approved by the United 682
States Food and Drug Administration. 683
191. Substituted Cathinones. —Unless specifically excepted, 684
listed in another schedule, or contained within a pharmaceutical 685
product approved by the United States Food and Drug 686
Administration, any material, compound, mixture, or preparation, 687
including its salts, isomers, esters, or ethers, and salts of 688
isomers, esters, or ethers, whenever the existence of such salts 689
is possible within any of the following specific chemical 690
designations: 691
a. Any compound containing a 2 -amino-1-phenyl-1-propanone 692
structure; 693
b. Any compound containing a 2 -amino-1-naphthyl-1-694
propanone structure; or 695
c. Any compound containing a 2 -amino-1-thiophenyl-1-696
propanone structure, 697
698
whether or not the compound is further modified: 699
(I) With or without substitution on the ring system to any 700
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 29 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy, 701
haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused 702
dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide 703
substituents; 704
(II) With or without substitution at the 3 -propanone 705
position with an alkyl substituent or removal of the methyl 706
group at the 3-propanone position; 707
(III) With or without substitution at the 2 -amino nitrogen 708
atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or 709
not further substituted in the ring system; or 710
(IV) With or without inclusion of the 2 -amino nitrogen 711
atom in a cyclic structure, including, but not limited to: 712
(A) Methcathinone. 713
(B) Ethcathinone. 714
(C) Methylone (3,4-Methylenedioxymethcathinone). 715
(D) 2,3-Methylenedioxymethcathinone. 716
(E) MDPV (3,4-Methylenedioxypyrovalerone). 717
(F) Methylmethcathinone. 718
(G) Methoxymethcathinone. 719
(H) Fluoromethcathinone. 720
(I) Methylethcathinone. 721
(J) Butylone (3,4-Methylenedioxy-alpha-722
methylaminobutyrophenone). 723
(K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 724
(L) BMDP (3,4-Methylenedioxy-N-benzylcathinone). 725
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 30 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(M) Naphyrone (Naphthylpyrovalerone). 726
(N) Bromomethcathinone. 727
(O) Buphedrone (alpha -Methylaminobutyrophenone). 728
(P) Eutylone (3,4-Methylenedioxy-alpha-729
ethylaminobutyrophenone). 730
(Q) Dimethylcathinone. 731
(R) Dimethylmethcathinone. 732
(S) Pentylone (3,4-Methylenedioxy-alpha-733
methylaminovalerophenone). 734
(T) Pentedrone (alpha -Methylaminovalerophenone). 735
(U) MDPPP (3,4-Methylenedioxy-alpha-736
pyrrolidinopropiophenone). 737
(V) MDPBP (3,4-Methylenedioxy-alpha-738
pyrrolidinobutyrophenone). 739
(W) MPPP (Methyl-alpha-pyrrolidinopropiophenone). 740
(X) PPP (Pyrrolidinopropiophenone). 741
(Y) PVP (Pyrrolidinovalerophenone) or 742
(Pyrrolidinopentiophenone). 743
(Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone). 744
(AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone). 745
(BB) F-MABP (Fluoromethylaminobutyrophenone). 746
(CC) Me-EABP (Methylethylaminobutyrophenone). 747
(DD) PBP (Pyrrolidinobutyrophenone). 748
(EE) MeO-PBP (Methoxypyrrolidinobutyrophenone). 749
(FF) Et-PBP (Ethylpyrrolidinobutyrophenone). 750
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 31 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 751
(HH) Dimethylone (3,4 -Methylenedioxy-N,N-752
dimethylcathinone). 753
(II) 3,4-Methylenedioxy-N,N-diethylcathinone. 754
(JJ) 3,4-Methylenedioxy-N-acetylcathinone. 755
(KK) 3,4-Methylenedioxy-N-acetylmethcathinone. 756
(LL) 3,4-Methylenedioxy-N-acetylethcathinone. 757
(MM) Methylbuphedrone (Methyl -alpha-758
methylaminobutyrophenone). 759
(NN) Methyl-alpha-methylaminohexanopheno ne. 760
(OO) N-Ethyl-N-methylcathinone. 761
(PP) PHP (Pyrrolidinohexanophenone). 762
(QQ) PV8 (Pyrrolidinoheptanophenone). 763
(RR) Chloromethcathinone. 764
(SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone. 765
192. Substituted Phenethylamines. —Unless specifically 766
excepted or unless listed in another schedule, or contained 767
within a pharmaceutical product approved by the United States 768
Food and Drug Administration, any material, compound, mixture, 769
or preparation, including its salts, isomers, esters, or ethers, 770
and salts of isomers, esters, or ethers, whenever the existence 771
of such salts is possible within any of the following specific 772
chemical designations, any compound containing a phenethylamine 773
structure, without a beta-keto group, and without a benzyl group 774
attached to the amine group, whether or not the compound is 775
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 32 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
further modified with or without substitution on the phenyl ring 776
to any extent with alkyl, alkylthio, nitro, alkoxy, thio, 777
halide, fused alkylenedi oxy, fused furan, fused benzofuran, 778
fused dihydrofuran, or fused tetrahydropyran substituents, 779
whether or not further substituted on a ring to any extent, with 780
or without substitution at the alpha or beta position by any 781
alkyl substituent, with or without substitution at the nitrogen 782
atom, and with or without inclusion of the 2 -amino nitrogen atom 783
in a cyclic structure, including, but not limited to: 784
a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 785
b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 786
c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 787
d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 788
e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 789
f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 790
g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 791
h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine). 792
i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 793
j. 2C-H (2,5-Dimethoxyphenethylamine). 794
k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 795
l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine ). 796
m. MDMA (3,4-Methylenedioxymethamphetamine). 797
n. MBDB (Methylbenzodioxolylbutanamine) or (3,4 -798
Methylenedioxy-N-methylbutanamine). 799
o. MDA (3,4-Methylenedioxyamphetamine). 800
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 33 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
p. 2,5-Dimethoxyamphetamine. 801
q. Fluoroamphetamine. 802
r. Fluoromethamphetam ine. 803
s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 804
t. DOB (4-Bromo-2,5-dimethoxyamphetamine). 805
u. DOC (4-Chloro-2,5-dimethoxyamphetamine). 806
v. DOET (4-Ethyl-2,5-dimethoxyamphetamine). 807
w. DOI (4-Iodo-2,5-dimethoxyamphetamine). 808
x. DOM (4-Methyl-2,5-dimethoxyamphetamine). 809
y. PMA (4-Methoxyamphetamine). 810
z. N-Ethylamphetamine. 811
aa. 3,4-Methylenedioxy-N-hydroxyamphetamine. 812
bb. 5-Methoxy-3,4-methylenedioxyamphetamine. 813
cc. PMMA (4-Methoxymethamphetamine). 814
dd. N,N-Dimethylamphetamine. 815
ee. 3,4,5-Trimethoxyamphetamine. 816
ff. 4-APB (4-(2-Aminopropyl)benzofuran). 817
gg. 5-APB (5-(2-Aminopropyl)benzofuran). 818
hh. 6-APB (6-(2-Aminopropyl)benzofuran). 819
ii. 7-APB (7-(2-Aminopropyl)benzofuran). 820
jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran). 821
kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran). 822
ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran). 823
mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran). 824
nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran). 825
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 34 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran). 826
pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran). 827
qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran). 828
rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran). 829
ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3-830
dihydrobenzofuran), 831
832
which does not includ e phenethylamine, mescaline as described in 833
subparagraph 20., substituted cathinones as described in 834
subparagraph 191., N -Benzyl phenethylamine compounds as 835
described in subparagraph 193., or methamphetamine as described 836
in subparagraph (2)(c)5. 837
193. N-Benzyl Phenethylamine Compounds. —Unless 838
specifically excepted or unless listed in another schedule, or 839
contained within a pharmaceutical product approved by the United 840
States Food and Drug Administration, any material, compound, 841
mixture, or preparation, inc luding its salts, isomers, esters, 842
or ethers, and salts of isomers, esters, or ethers, whenever the 843
existence of such salts is possible within any of the following 844
specific chemical designations, any compound containing a 845
phenethylamine structure without a beta-keto group, with 846
substitution on the nitrogen atom of the amino group with a 847
benzyl substituent, with or without substitution on the phenyl 848
or benzyl ring to any extent with alkyl, alkoxy, thio, 849
alkylthio, halide, fused alkylenedioxy, fused furan, fu sed 850
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 35 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
benzofuran, or fused tetrahydropyran substituents, whether or 851
not further substituted on a ring to any extent, with or without 852
substitution at the alpha position by any alkyl substituent, 853
including, but not limited to: 854
a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-855
methoxybenzyl)]phenethylamine). 856
b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2-857
hydroxybenzyl)]phenethylamine). 858
c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2-859
fluorobenzyl)]phenethylamine). 860
d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3-861
methylenedioxybenzyl)]phenethylamine). 862
e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-863
methoxybenzyl)]phenethylamine). 864
f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2-865
hydroxybenzyl)]phenethylamine). 866
g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2-867
fluorobenzyl)]phenethylamine). 868
h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3-869
methylenedioxybenzyl)]phenethylamine). 870
i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2-871
methoxybenzyl)]phenethylamine). 872
j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2-873
methoxybenzyl)]phenethylamine). 874
k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2-875
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 36 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
methoxybenzyl)]phenethylamine). 876
l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-877
methoxybenzyl)]phenethylamine). 878
m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2-879
hydroxybenzyl)]phene thylamine). 880
n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2-881
fluorobenzyl)]phenethylamine). 882
o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3-883
methylenedioxybenzyl)]phenethylamine). 884
p. 25H-NBOMe (2,5-Dimethoxy-[N-(2-885
methoxybenzyl)]phenethylamine). 886
q. 25H-NBOH (2,5-Dimethoxy-[N-(2-887
hydroxybenzyl)]phenethylamine). 888
r. 25H-NBF (2,5-Dimethoxy-[N-(2-889
fluorobenzyl)]phenethylamine). 890
s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2-891
methoxybenzyl)]phenethylamine), 892
893
which does not include substituted cathinones as described in 894
subparagraph 191. 895
194. Substituted Tryptamines. —Unless specifically excepted 896
or unless listed in another schedule, or contained within a 897
pharmaceutical product approved by the United States Food and 898
Drug Administration, any material, compound, mixture, or 899
preparation containing a 2 -(1H-indol-3-yl)ethanamine, for 900
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 37 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
example tryptamine, structure with or without mono - or di-901
substitution of the amine nitrogen with alkyl or alkenyl groups, 902
or by inclusion of the amino nitrogen atom in a cyclic 903
structure, whether or not substituted at the alpha position with 904
an alkyl group, whether or not substituted on the indole ring to 905
any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy 906
groups, including, but not limited to: 907
a. Alpha-Ethyltryptamine. 908
b. Bufotenine. 909
c. DET (Diethyltryptamine). 910
d. DMT (Dimethyltryptamine). 911
e. MET (N-Methyl-N-ethyltryptamine). 912
f. DALT (N,N-Diallyltryptamine). 913
g. EiPT (N-Ethyl-N-isopropyltryptamine). 914
h. MiPT (N-Methyl-N-isopropyltryptamine). 915
i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 916
j. 5-Hydroxy-N-methyltryptamine. 917
k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 918
l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 919
m. Methyltryptamine. 920
n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 921
o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 922
p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 923
q. DiPT (N,N-Diisopropyltryptamine). 924
r. DPT (N,N-Dipropyltryptamine). 925
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 38 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 926
t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 927
u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine). 928
v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine). 929
w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine). 930
x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine). 931
y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-932
isopropyltryptamine). 933
z. Methyl-alpha-ethyltryptamine. 934
aa. Bromo-DALT (Bromo-N,N-diallyltryptamine), 935
936
which does not include tryptamine, psilocyn as described in 937
subparagraph 34., or psilocybin as described in subparagraph 33. 938
195. Substituted Phenylcyclohexylamines. —Unless 939
specifically excepted or unless listed in another schedule, or 940
contained within a pharmaceutical product approved by the United 941
States Food and Drug Administration, any material, compound, 942
mixture, or preparation containing a phenylcyclohexylamine 943
structure, with or without any substitution on the phenyl ring, 944
any substitution on the cyclohexyl ring, any replacement of the 945
phenyl ring with a thiophenyl or benzothiophenyl ring, with or 946
without substitution on the amine with alkyl, dialkyl, or alkoxy 947
substituents, inclusion of the nitrogen in a cyclic structure, 948
or any combination of the above, including, but not limited to: 949
a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 950
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 39 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(Benocyclidine). 951
b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog 952
of phencyclidine). 953
c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine 954
analog of phencyclidine). 955
d. PCPr (Phenylcyclohexylpropylamine). 956
e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene 957
analog of phencyclidine). 958
f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)). 959
g. PCMPA (Phenylcyclohexyl(methoxypropylamine)). 960
h. Methoxetamine. 961
i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine). 962
j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine). 963
k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine). 964
l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine). 965
m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine). 966
n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine). 967
o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine). 968
p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine). 969
q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine). 970
r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine). 971
196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2-972
piperidinylidene]-benzenesulfonamide. 973
197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-974
piperidinylidene]-benzenesulfonamide. 975
HB 1323 2022
CODING: Words stricken are deletions; words underlined are additions.
hb1323-00
Page 40 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
198. AH-7921, 3,4-dichloro-N-[[1-976
(dimethylamino)cyclohexyl]methyl] -benzamide. 977
199. U47700, trans-3,4-dichloro-N-[2-978
(dimethylamino)cyclohexyl]-N-methyl-benzamide. 979
200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine, 980
dihydrochloride. 981
Section 2. This act does not limit the authority of the 982
Attorney General pursuant to s. 893.035 or s. 893.0355, Florida 983
Statutes. 984
Section 3. This act shall take effect upon becoming a law. 985